ID   538-MG-BA
AC   CVCL_LM82
DR   DSMZ; ACC-805
DR   DSMZCellDive; ACC-805
DR   Wikidata; Q54603833
RX   PubMed=30509096;
CC   Doubling time: 28 hours (PubMed=30509096); ~30-35 hours (DSMZ=ACC-805).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): DSMZ=ACC-805
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 14
ST   D21S11: 28,32.2
ST   D2S1338: 17,18
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 11,12
ST   Penta E: 12,21
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
RX   PubMed=30509096; DOI=10.4149/neo_2018_180427N278;
RA   MacLeod, Roderick A.F.
RA   Schneider, Bjorn
RA   Sivakova, Ivana
RA   Nagel, Stefan
RA   Dirks, Wilhelm Gerhard
RA   Mraz, Peter
RA   Kubikova, Eliska
RA   Perzelova, Anna
RT   "High level EGFR amplification in a newly established glioblastoma
RT   cell line 170-MG-BA.";
RL   Neoplasma 66:109-117(2019).
//